Kleiner Device Labs

Kleiner Device Labs

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Kleiner Device Labs is a U.S.-based medical device innovator targeting the spinal surgery market with surgeon-designed implants and instruments. The company, founded in 2013 by Dr. Jeff Kleiner, aims to address the high costs and poor outcomes associated with failed spinal fusions by simplifying surgical technique and enhancing efficacy. Its core technology is the KG2 SURGE system, which is designed for both open and minimally invasive procedures. The company appears to be in a commercial or early-revenue stage, marketing its flagship system directly to surgeons and hospitals.

Spinal DisordersOrthopedics

Technology Platform

Surgeon-designed spinal implant systems and instrument sets focused on simplifying technique and improving outcomes for open and minimally invasive spinal fusion surgery.

Opportunities

The growing global spinal surgery market, driven by an aging population and a shift towards minimally invasive techniques, presents a significant opportunity.
The company's focus on reducing costly revision surgeries aligns perfectly with the healthcare industry's value-based care initiatives, creating a strong economic argument for adoption by hospitals and payors.

Risk Factors

The company faces intense competition from large, established medical device giants with vast sales networks and surgeon relationships.
Regulatory hurdles and the need for consistent reimbursement approval for its devices pose ongoing challenges to market access and profitability.

Competitive Landscape

Kleiner Device Labs competes in the highly consolidated spinal implants market, dominated by multinational corporations like Medtronic, Stryker, and Johnson & Johnson. Its differentiation is its surgeon-founded, ergonomic design focused on procedural efficiency, but it must overcome significant barriers in sales, marketing, and brand recognition to capture market share.